Alhua Huogan Pain Relieving Patch

Description

The provided data does not specify the chemical name, physical characteristics, or inactive ingredients of the drug. Therefore, a detailed description cannot be formulated based on the available information. Further details are required to create a comprehensive description.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with muscles and joints. Specifically, it is effective for conditions such as simple backache, sprains, strains, bruises, and arthritis.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children 12 years of age and over should begin by cleaning and drying the affected area thoroughly. Following this, the healthcare professional should instruct the patient to open the pouch and remove the patch. The protective backing must be peeled off, allowing the sticky side of the patch to be applied directly to the affected area.

The patch should be applied for a duration of less than 4 hours per day. After handling the patch, it is essential for the patient to wash their hands with soap to prevent any unintended contact with other areas of the body or surfaces.

For children under 12 years of age, it is recommended that a healthcare professional be consulted prior to use to determine the appropriate course of action.

Contraindications

Use of this product is contraindicated in the following situations:

• The product should not be used otherwise than as directed.

• Contact with eyes must be avoided to prevent irritation or injury.

• Application on wounds, damaged, or irritated skin is contraindicated due to the risk of exacerbating the condition.

• Tight bandaging is not recommended, as it may lead to adverse effects.

• The product should not be used if any changes in its properties are observed, as this may indicate instability or contamination.

Warnings and Precautions

For external use only. It is imperative that healthcare professionals advise patients to adhere strictly to this guideline to prevent unintended ingestion or misuse.

In the event of accidental ingestion, immediate medical assistance should be sought. Patients should be instructed to contact a Poison Control Center or seek emergency medical help without delay.

Healthcare providers should monitor patients closely and advise them to discontinue use and consult a physician if any of the following occur: the condition worsens, symptoms persist beyond 7 days, or if symptoms resolve and then recur within a few days. Additionally, patients should be alerted to seek medical attention if they experience rash, itching, or excessive skin irritation, as these may indicate an adverse reaction.

In summary, vigilance in monitoring patient responses and adherence to these precautions is essential for the safe use of this product.

Side Effects

For external use only. Patients are advised to stop use and consult a doctor if conditions worsen, if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days. Additionally, if a rash, itching, or excessive skin irritation develops, medical advice should be sought.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified in the available data. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Alhua Huogan Pain Relieving Patch (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a doctor before use. For adolescents and adults aged 12 years and older, the patch should be applied for less than 4 hours a day.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is currently no information available regarding the use of ALHUA HUOGAN PAIN RELIEVING PATCH during pregnancy. This includes a lack of data on safety concerns, dosage modifications, or any special precautions that should be taken when considering the use of this product in pregnant patients. Healthcare professionals should exercise caution and consider the absence of data when advising women of childbearing potential or those who are pregnant.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment may not have specific dosage adjustments, special monitoring, or safety considerations outlined in the prescribing information. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment and monitoring of these patients.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved. Common symptoms of overdose may include, but are not limited to, altered mental status, cardiovascular instability, and respiratory distress.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs. The use of activated charcoal may be considered if the patient presents within a suitable timeframe and if the ingestion was recent.

Furthermore, it is recommended to consult local poison control centers or toxicology experts for guidance on specific management strategies tailored to the substance involved. Continuous assessment and supportive measures are critical in managing the patient’s condition effectively.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to instruct patients to discontinue use and consult a doctor if their condition worsens or if symptoms persist for more than 7 days. Patients should also be informed to stop using the product and seek medical advice if symptoms resolve and then recur within a few days, or if they experience rash, itching, or excessive skin irritation.

Providers should emphasize the necessity of using the product strictly as directed and to avoid contact with the eyes. Patients should be cautioned against applying the product on wounds, damaged, or irritated skin. Additionally, it is crucial to inform patients not to bandage the area tightly after application and to refrain from using the product if any changes in its properties are observed.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product in a cool, dry place, away from direct sunlight. Care should be taken to protect the product from excessive moisture and heat to maintain its integrity and efficacy. Proper handling and storage conditions are crucial to ensure the product remains effective throughout its shelf life.

Additional Clinical Information

The route of administration for the treatment is topical, with a recommendation to apply the patch for less than 4 hours a day. Clinicians should counsel patients to avoid contact with the eyes and not to apply the patch on wounds, damaged, or irritated skin. It is advised not to bandage the area tightly. Patients should be instructed to discontinue use and consult a doctor if their condition worsens, if symptoms persist for more than 7 days, or if symptoms resolve and then recur within a few days. Additionally, they should seek medical attention if a rash, itching, or excessive skin irritation develops. It is important to keep the product out of reach of children, and in the event of ingestion, patients should seek medical help or contact a Poison Control Center immediately.

Drug Information (PDF)

This file contains official product information for Alhua Huogan Pain Relieving Patch, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)